Medtelligence

Lipid-Lowering Drug Interactions in Cardiovascular Agents

Lipid-Lowering Drug Interactions in Cardiovascular Agents
RestartResume
Dr. Barbara Wiggins reviews the pharmacokinetic data behind drug interactions with treatments for complex lipid abnormalities
  • Overview

    Joining Dr. Alan Brown to discuss the pharmacokinetic data behind drug interactions between treatments for complex lipid abnormalities is Dr. Barbara Wiggins, Pharm.D, clinical pharmacy specialist in cardiology at the Medical University of South Carolina and adjunct professor at the South Carolina School of Pharmacy. Dr. Wiggens has served as a member of the cardiovascular expert panel for the United States Pharmacopoeia. 

Facebook Comments

Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free